AMSBIO: Generation of Muscle Cells in 3 Easy Steps

Hits:632   Date: 3/3/2020

AMSBIO offers a Skeletal Muscle Differentiation kit that enables you to differentiate human pluripotent stem cells to skeletal muscle myotubes with high yields, without cell sorting or genetic manipulation. Myotubes are contractile, express typical muscle markers that show striated sarcomeres. 
 

Until recently methods of studying muscular disease and potential therapies were dependent on invasive muscle biopsies to produce limited batches of primary cells. Use of primary cells presents challenges, not only in the collection process but also related to inconsistencies in cell growth, behaviour and life span, making it difficult to generate reliable experimental models.

Using AMSBIO's revolutionary Skeletal Muscle Differentiation kit allows researchers to generate muscle from human pluripotent stem cells in 3 easy steps, via satellite-like or progenitor cells and myoblasts that then fuse to multinucleated myotubes in the third step. 
 

Jason D Doles, Ph.D, an assistant Professor of Biochemistry and Molecular Biology and head of the Doles Lab in Rochester, Minnesota commented “The myotube differentiation kit from AMSBIO is simple to use and it has produced consistent results every time.” Dr Doles and the research team in his Skeletal Muscle Wasting and Progenitor Cell Biology group are currently studying muscle regeneration, wasting disorders and stem cell activation using diverse experimental model systems and cutting-edge cell and molecular biology tools and technologies.

Tested on a wide range of human embryonic and induced pluripotent stem cell lines the new kit follows a simple 3-step process of media changes and cell passaging. Eliminating the need for cell sorting or transfection of myogenic transcription factors, the Skeletal Muscle Differentiation kit protocol generates a highly pure population of approximately 70 per cent skeletal muscle myotubes in a reproducible fashion.
 

For further information on the new Skeletal Muscle Differentiation Kit please visit http://www.amsbio.com/skeletal-muscle-differentiation-kits.aspx  or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com. 

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. 

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.

 
Image captions:  262/262A: Skeletal muscle precursor cells (stage II and III) produced with the Skeletal Muscle Differentiation Kit (courtesy: Douglas Smith - Doles Lab) ; 262B:  Schematic of muscle generation in 3 easy steps

Worldwide HQ 

AMS Biotechnology (AMSBIO)
184 Milton Park
Abingdon
Oxon OX14 4SE
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com 
Web www.amsbio.com
 
North American HQ
 
AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033 
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web www.amsbio.com